共 115 条
- [1] Kyriakos M., Benign notochordal lesions of the axial skeleton: a review and current appraisal, Skelet Radiol, 40, 9, pp. 1141-1152, (2011)
- [2] Yakkioui Y., van Overbeeke J.J., Santegoeds R., van Engeland M., Temel Y., Chordoma: the entity, Biochim Biophys Acta, 1846, 2, pp. 655-669, (2014)
- [3] McMaster M.L., Goldstein A.M., Bromley C.M., Ishibe N., Parry D.M., Chordoma: incidence and survival patterns in the United States, 1973–1995, Cancer Causes Control, 12, 1, pp. 1-11, (2001)
- [4] Lee I.J., Lee R.J., Fahim D.K., Prognostic factors and survival outcome in patients with chordoma in the United States: a population-based analysis, World Neurosurg, 104, pp. 346-355, (2017)
- [5] Whelan J., McTiernan A., Cooper N., Wong Y.K., Francis M., Vernon S., Et al., Incidence and survival of malignant bone sarcomas in England 1979–2007, Int J Cancer, 131, 4, pp. E508-E517, (2012)
- [6] Jones P.S., Aghi M.K., Muzikansky A., Shih H.A., Barker F.G., Curry W.T., Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database, J Clin Neurosci, 21, 9, pp. 1490-1496, (2014)
- [7] Wu Z., Zhang J., Zhang L., Jia G., Tang J., Wang L., Et al., Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution, Neurosurg Rev, 33, 4, pp. 451-456, (2010)
- [8] Walcott B.P., Nahed B.V., Mohyeldin A., Coumans J.V., Kahle K.T., Ferreira M.J., Chordoma: current concepts, management, and future directions, Lancet Oncol, 13, 2, pp. e69-e76, (2012)
- [9] Stacchiotti S., Gronchi A., Fossati P., Akiyama T., Alapetite C., Baumann M., Et al., Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group, Ann Oncol, 28, 6, pp. 1230-1242, (2017)
- [10] Rich T.A., Schiller A., Suit H.D., Mankin H.J., Clinical and pathologic review of 48 cases of chordoma, Cancer, 56, 1, pp. 182-187, (1985)